These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4425061)

  • 1. Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis.
    Rosenbluth M; Chernick V
    Arch Dis Child; 1974 Aug; 49(8):606-10. PubMed ID: 4425061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of fluid deposition in humans following mist tent therapy.
    Bau SK; Aspin N; Wood DE; Levison H
    Pediatrics; 1971 Oct; 48(4):605-12. PubMed ID: 5114748
    [No Abstract]   [Full Text] [Related]  

  • 3. Mist tent therapy of cystic fibrosis.
    Matthews LW; Doershuk CF; Miller ST; Pittman S; Lough M
    J Asthma Res; 1968 Jun; 5(4):267-76. PubMed ID: 4969879
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Mists and aerosols: new studies, new thoughts.
    Taussig LM
    J Pediatr; 1974 Apr; 84(4):610-22. PubMed ID: 4600571
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of jet-type and ultrasonic nebulizers in mist tent therapy for cystic fibrosis.
    Doershuk CF; Matthews LW; Gillespie CT; Lough MD; Spector S
    Pediatrics; 1968 Apr; 41(4):723-32. PubMed ID: 5643980
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluid deposition in airways after mist tent therapy.
    Chadwick DL
    Pediatrics; 1972 Apr; 49(4):630-1. PubMed ID: 5013431
    [No Abstract]   [Full Text] [Related]  

  • 7. Deoxyribonucleic acid output in the sputum from cystic fibrosis patients.
    Carswell F; Robinson DW; Ward CC; Waterfield MR
    Eur J Respir Dis; 1984 Jan; 65(1):53-7. PubMed ID: 6705858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pus, deoxyribonucleic acid, and sputum viscosity.
    Picot R; Das I; Reid L
    Thorax; 1978 Apr; 33(2):235-42. PubMed ID: 26989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of nightly mist tent therapy for patients with cystic fibrosis.
    Chang N; Levison H; Cunningham K; Crozier DN; Grosett O
    Am Rev Respir Dis; 1973 Apr; 107(4):672-5. PubMed ID: 4697676
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve.
    Motoyama EK; Gibson LE; Zigas CJ
    Pediatrics; 1972 Aug; 50(2):299-306. PubMed ID: 5045357
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro and in vivo effect of various substances on the viscosity of sputum from patients with cystic fibrosis].
    Mastella G; Marcer V; Battaglino G
    Fracastoro; 1970; 63(3):479-507. PubMed ID: 5517025
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical properties of sputum. IV. Effects of 100 per cent humidity and water mist.
    Dulfano MJ; Adler K; Wooten O
    Am Rev Respir Dis; 1973 Jan; 107(1):130-2. PubMed ID: 4683316
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative interaction of water and cystic fibrosis sputum.
    Lifschitz MI; Denning CR
    Am Rev Respir Dis; 1970 Sep; 102(3):456-8. PubMed ID: 5450910
    [No Abstract]   [Full Text] [Related]  

  • 14. Mist tent therapy of the obstructive pulmonary lesion of cystic fibrosis.
    Matthews LW; Doershuk CF; Spector S
    Pediatrics; 1967 Feb; 39(2):176-85. PubMed ID: 6017955
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of sputum viscosity in a cone-plate viscometer. I. Characteristics of sputum viscosity.
    Lieberman J
    Am Rev Respir Dis; 1968 Apr; 97(4):654-61. PubMed ID: 5644328
    [No Abstract]   [Full Text] [Related]  

  • 16. Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis.
    Lieberman J
    JAMA; 1968 Jul; 205(5):312-3. PubMed ID: 5694947
    [No Abstract]   [Full Text] [Related]  

  • 17. Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Rubin BK
    N Engl J Med; 1992 Aug; 327(8):571. PubMed ID: 1635583
    [No Abstract]   [Full Text] [Related]  

  • 18. Output characteristics and clinical efficacy of ultrasonic nebulizers.
    Goddard RF; Mercer TT; O'Neill PX; Flores RL; Sanchez R
    J Asthma Res; 1968 Jun; 5(4):355-68. PubMed ID: 4875003
    [No Abstract]   [Full Text] [Related]  

  • 19. Nocturnal mist therapy in cystic fibrosis.
    Norman AP
    Practitioner; 1971 Jun; 206(236):786-90. PubMed ID: 5581863
    [No Abstract]   [Full Text] [Related]  

  • 20. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C; Burke JF
    Eur Respir J; 1990 Jan; 3(1):19-23. PubMed ID: 2107097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.